.

Department of Urologic Surgery

Contact Us
 

Department of Urologic Surgery Administrative Office
A-1302 Medical Center North
Vanderbilt University
Medical Center
Nashville, TN 37232-2765
Fax: (615) 322-8990
 
Vanderbilt Adult Urology Clinic
3823 The Vanderbilt Clinic
 Vanderbilt University Medical Center
 Nashville, TN 37232-5770
Phone: (615) 322-2880

Clinical Trials

 

The Department of Urologic Surgery’s Clinical Trials Office has been actively involved in a number of national and university-based trials that allow our patients access to cutting-edge medications, techniques, and diagnostic modalities.  Clinical trials are available for many different disease processes.  Our experienced staff can quickly determine by phone whether or not you may qualify for a certain trial.

Listed below are several of the current trials that are open for enrollment. If you are interested in finding out whether or not you qualify for participation in one of these trials, please contact Pamela Steele, RN, BSN, CCRC at (615) 343-2120 or pamela.steele@Vanderbilt.Edu

 

Active Clinical Trials for Urologic Surgery

 

BLADDER CANCER

  • Rapamycin Study:  A Combined Phase 1 and Phase 2 Study of Albumin-bound Rapamycin Nanoparticles (nab-rapamycin, ABI-009) in the Treatment of BCG Refractory or Recurrent Nonmuscle Invasive Transitional Cell Bladder Cancer 
  • Genomic Health:  Genomic Markers in Transitional Cell Cancer of the Bladder, Renal Pelvis and Ureter:  Sample Acquisition for Methods Development and Discovery. 
  • Nutrition RC Pilot Study:  A Pilot Study of Perioperative Oral Nutrition Supplementation to Improve Nutritional Status and Clinical Outcomes in Patients Undergoing Radical Cystectomy. 

PROSTATE CANCER

  • PROSPER:  A Multinational, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer.  

URINARY INCONTINENCE

  • Cook Myosite SUI:  A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR with Placebo in Female Subjects with Stress Urinary Incontinence 

This page was last updated April 9, 2015 and is maintained by